http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_343a543359b813d89bb00ea701007642
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Fritsch |
| name | Christine Fritsch |
| given-name | Christine |
| organization-name | Authors' Affiliations: 1Oncology Disease Area, 2Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland; 3Oncology Disease Area, Novartis Institutes for Biomedical Research, Emeryville, California; 4Oncology Translational Medicine, BU Oncology, Novartis Pharma Inc.; 5Developmental and Molecular Pathways, and 6Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 1Oncology Disease Area and Novartis Institutes for Biomedical Research, Oncology Disease Area, CH-4002 Basel, Switzerland; and Oncology Research, Novartis Institutes for Biomedical Research, CH-4056, Basel, Switzerland Authors' Affiliations: 1Novartis Institutes for BioMedical Research, Disease Area Oncology; 2Novartis Institutes for BioMedical Research, Global Discovery Chemistry; 3Novartis Institutes for BioMedical Research, Center for Proteomic Chemistry; 4Novartis Pharma AG, Oncology Translational Medicine, Basel, Switzerland; 5Novartis Pharma AG, Oncology Translational Medicine; 6Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Cambridge, Massachusetts; and 7Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Shangai, China Department of Medicine, Washington University School of Medicine, Authors' Affiliations: 1Disease Area Oncology, 2Center for Proteomic Chemistry, 3Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Basel, Switzerland; 4Development and Molecular Pathways, 5Oncology Drug Discovery and Preclinical Research, Sanofi-Aventis, Vitry-sur-Seine, France; and 6Disease Area Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts Authors' Affiliations: 1Oncology Disease Area Research; 2Global Discovery Chemistry/Oncology and Exploratory Chemistry; 3MAP Group; 4Chemical and Pharmaceutical Profiling Group, Novartis Institutes for Biomedical Research, Emeryville, California; 5Developmental Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; 6Oncology Disease Area Research; and 7Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland |
Incoming Links
Total number of triples: 35.